Recent Updates
Recently added Catalysts

Fairmount Funds Management LLC

Track Fairmount Funds Management LLC's latest SEC 13F filing: top biotech and life-sciences stock positions, portfolio weights, largest holdings, and quarter-over-quarter changes.
Updated quarterly · Last refreshed Jun 19, 2026
Showing 6 Stocks Out Of 12. Click On The Tickers For More Details
Stock Compnay Name Shares Held Market Value % of Portfolio QoQ Change
GLTO
GLTO
DAMORA THERAPEUTICS INC
8.71 M
225.67 M
16.3
DNTH
DNTH
DIANTHUS THERAPEUTICS INC
2.54 M
212.92 M
15.4
COGT
COGT
COGENT BIOSCIENCES INC
5.50 M
211.83 M
15.3
AGLE
AGLE
SPYRE THERAPEUTICS INC
4.02 M
202.67 M
14.6
ORKA
ORKA
ORUKA THERAPEUTICS INC
3.71 M
181.74 M
13.1
VRDN
VRDN
VIRIDIAN THERAPEUTICS INC
3.91 M
76.57 M
5.5
API Access

Simple Pricing, Powerful Insights

Full access to Biotech/Pharma investing and trading opportunities.

No hidden fees, powerful insights, tools, and exclusive real time data to maximize your biotech profits.

yearly_arrow
For Visitors

Preview only and discover why serious investors choose our Premium Plan for comprehensive data.

$0.00 / Month

  • Includes 3 day Elite access
For Serious Investor and Traders
Recommended

Your Key to Consistent Profits: Save Big with Our Annual Plan at Just $19.00 per Month

Only $24.00/ Month

  • Searchable FDA Calendar with 1000+ catalysts like clinical readouts and PDUFA
  • Full access to drug pipelines and company health for informed decisions
  • Probability of Approval (PoA) score cards for each asset
  • Download all data in Excel for your models
  • Historical FDA decisions to shape strategic plans
  • Track biotech earnings and critical catalyst events
  • Monitor insider trading and hedge fund holdings for market insights
  • Options flow and strategy modules (screeners and playbooks)
  • Advanced portfolio tools for smart biotech investments
  • Research on 1,100+ companies and clinical trials
  • Real-time market updates, trends, and analysis
  • Live news feed with customizable alerts (tickers, drugs, indications)
  • Exclusive courses on biotech investment basics
Market Value

$ 1.38 B

Holdings

12

Period

Q1 2026

Holdings in Top 20

99.8 %

QoQ Changes

5.37 %

Top 20 Holdings